MannKind

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.

About MNKD

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.

CEO

Michael E. Castagna

CEOMichael E. Castagna

Employees

407

Employees407

Headquarters

Danbury, Connecticut

HeadquartersDanbury, Connecticut

Founded

1991

Founded1991

Employees

407

Employees407

MNKD Key Statistics

Market cap

1.14B

Market cap1.14B

Price-Earnings ratio

39.12

Price-Earnings ratio39.12

Dividend yield

—

Dividend yield—

Average volume

2.45M

Average volume2.45M

High today

$3.92

High today$3.92

Low today

$3.74

Low today$3.74

Open price

$3.92

Open price$3.92

Volume

2.32M

Volume2.32M

52 Week high

$7.63

52 Week high$7.63

52 Week low

$3.51

52 Week low$3.51

MNKD News

TipRanks 3d

MannKind assumed with a Buy at H.C. Wainwright

H.C. Wainwright assumed coverage of MannKind (MNKD) with a Buy rating and $9 price target The firm views the company’s pipeline as largely overlooked at current...

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own MNKD. This list is generated using Robinhood data, and it’s not a recommendation.